Connect your AI

Astrana Health ASTH Equity method investment, impairment

Equity method investment, impairment at other companies

Bel FuseBELFB

$13.1M—

Nexstar Media Group, Inc.NXST

$95.25M—

WelltowerWELL

$0—

NRG EnergyNRG

$9.75M+457%

TwilioTWLO

$80.6M—

LyondellBasell Industries N.V.LYB

$1M-69.2%

Other financials

Income statement

Revenue$965.1M+55.6%

Gross profit$105.7M+48.2%

Operating income$28.5M+38.6%

Net income$14.4M+116%

EPS (diluted)$0.29+107%

Balance sheet

Cash & equivalents$478.4M+85.0%

Total debt$1.1B+136%

Total equity$800.3M+7.4%

Total assets$2.4B+77.2%

Cash flow

Operating cash flow$68.1M+309%

CapEx$4.0M+30.3%

Free cash flow$64.1M+372%

Valuation

Market cap$2.1B-3.0%

Profitability

Gross margin10.7%-1.3pp

Operating margin2.5%-1.1pp

Net margin0.9%—

FCF margin4.6%—

Returns & leverage

Return on equity3.9%—

Debt / equity1.3×+0.7×

Current ratio1.3×-0.4×

Where this comes from

Reported directly by Astrana Health in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment.

The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Astrana Health's equity method investment, impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Astrana Health's equity method investment, impairment?: Astrana Health (ASTH) reported equity method investment, impairment of $0 in Q1 2026.